Breast Reconstruction Market Key Players and Opportunities by 2028

The breast reconstruction market is expected to reach US$ 945.27 million by 2028 from US$ 593.61 million in 2020; it is estimated to grow at a CAGR of 6.1% during 2021–2028.

Breast reconstruction is the surgical process of rebuilding the shape and look of a breast, most commonly in women who have had surgery as a part of breast cancer treatment. To reconstruct a natural-looking breast, the reconstruction process is done by using autologous tissue, prosthetic implants, or a combination of both .

The growth of the breast reconstruction market is attributed to the factors such as the high prevalence of breast cancer, and new product launches and FDA approvals. However, low awareness regarding reimbursement policies hinders the market growth.

Market Insights

High Prevalence of Breast Cancer

Breast cancer is one of the most common types of cancer observed among women. It is majorly characterized by the development of lumps in breasts, inversion of nipples, change in breast shape, release of fluids from nipples, red or scaly patches on skin, dimpling of the skin, and pain and soaring of nipples. Breast cancer is treated using mastectomy, a procedure that includes removal of entire breast through a surgical process. Breast reconstruction surgeries are used to rebuild the breasts after mastectomy. Implant reconstruction and autologous or flap reconstruction are the two main techniques used in these surgeries. With the increasing prevalence of breast cancer worldwide, many women are opting for reconstruction procedures to regain the original shape of their breasts after the mastectomy. According to breastcancer.org, as of January 2018, over 3.1 million women in the US had a history of breast cancer, including those who were undergoing a treatment and those who had undergone treatments in the past. Further, according to a study published by the World Health Organization (WHO), ~2.3 million women across the world were newly diagnosed with breast cancer in 2020. In addition, according to a study published in the journal of American Society of Clinical Oncology in 2020, ~1 in 29 women in India suffers from breast cancer at some point in life. Similarly, according to the breastcancercare.org.uk, the UK had ~691,000 women diagnosed with breast cancer and this number is estimated to reach 840,000 by 2020. Similar trends of rise in number of breast cancer cases have been observed in other parts of the world. The increasing prevalence of breast cancer, coupled with the growing preference for breast reconstruction procedures post mastectomy, is bolstering the market growth.

Breast Reconstruction Market: Strategic Insights

Technology -Based Insights

The breast reconstruction market, by technology, is segmented into inframammary, peri-areolar, trans-axillary, and transumbilical. The inframammary segment held the largest share of the market in 2020, and the peri-areolar segment is anticipated to register the highest CAGR in the market during the forecast period.

Type-based Insights

By type, the breast reconstruction market is bifurcated into breast implants and implants accessories. The breast implants segment held a larger share of the market in 2020, and the same segment is anticipated to register a higher CAGR in the market during the forecast period.

Placement -based Insights

By Placement, the breast reconstruction market is segmented into dual-plane insertion, subglandular insertion, and submuscular insertion. The dual plane insertion segment held the largest share of the market in 2020. Also, the same segment is anticipated to register the highest CAGR in the market during the forecast period.

Procedure -based Insights

By Procedure, the breast reconstruction market is segmented into immediate procedures, delayed procedures, and revision procedures. In 2020, the immediate procedures segment held the largest share of the market. Also, the market for the same segment is expected to grow at the fastest rate during the coming years.

Product launches and approvals are the commonly adopted strategies by companies to expand their global footprints and product portfolios. Moreover, the breast reconstruction market players focus on the collaboration strategy to enlarge their clientele, which, in turn, permits them to maintain their brand name globally.

The regional trends and factors influencing the Breast Reconstruction Market throughout the forecast period have been thoroughly explained by the analysts at The Insight Partners. This section also discusses Breast Reconstruction Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Breast Reconstruction Market Report Scope

Breast Reconstruction Market Players Density: Understanding Its Impact on Business Dynamics

The Breast Reconstruction Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

By Technology

• Inframammary
• Peri-Areolar
• Trans-Axillary
• Transumbilical

By Type

• Breast Implants
• Implants accessories

By Placement

• Dual Plane Insertion
• Subglandular Insertion
• Submuscular Insertion

By Procedure

• Immediate Procedures
• Delayed Procedures
• Revision Procedures

By Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • France
  • Germany
  • Italy
  • UK
  • Spain
  • Rest of Europe
• Asia Pacific (APAC)
  • China
  • India
  • South Korea
  • Japan
  • Australia
  • Rest of Asia Pacific
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
• South and Central America (SCAM)
  • Brazil
  • Argentina
  • Rest of South and Central America

Company Profiles

• Allergan Plc
• Mentor Worldwide LLC (Subsidiary of Johnson & Johnson)
• Sientra Inc.
• GC Aesthetics PLC
• POLYTECH Health & Aesthetics GmbH
• HANSBIOMED CO. LTD
• IDEAL IMPLANT INCORPORATED
• Guangzhou Wanhe Plastic Materials Co., Ltd.
• Establishment Labs S.A.
• Groupe Sebbin SAS